Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens:Bioequivalence of PVP Formulations

Dermatitis, Contact Clinical Trial

Official title:
Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens: Bioequivalence of Polyvinylpyrrolidone (PVP) Formulations

Status Completed

Clinical Trial Summary

Open, prospective, multi-center study to evaluate the bioequivalence of povidone (PVP) formulations of 2 T.R.U.E. TEST allergens: fragrance mix and thimerosal.

Clinical Trial Description

Bioequivalence will be determined in 40 adult subjects (20 per allergen), who have a clinical history of contact dermatitis and have tested positive to fragrance mix or thimerosal. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00612768
Study type	Interventional
Source	Allerderm
Contact
Status	Completed
Phase	Phase 2
Start date	January 2008
Completion date	October 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00929981` - A Study To Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Patients
Active, not recruiting	`NCT00779792` - Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation	Phase 4
Completed	`NCT00795951` - Clinical Evaluation of T.R.U.E. TEST in Children and Adolescents	Phase 4
Recruiting	`NCT05492721` - Comparing Tissue Adhesives in Port Site Closure	Phase 3
Active, not recruiting	`NCT02614248` - The Use of Coconut Oil for the Prevention and Treatment of Diaper Dermatitis in the NICU Population	N/A
Not yet recruiting	`NCT01011621` - Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis	Phase 3